Figure 4. Relationship between risk score, m6A regulatory genes and clinicopathologic characteristics. (A, B) Heatmaps showed the expression levels of different m6A regulatory genes in low-risk and high-risk patients. The distribution of clinicopathological features in low-risk and high-risk groups was compared. (C) ROC curve shows the signature of risk prediction efficiency in endocrine system tumors.